Medacta Group H1 2026 revenue up nearly 10% to EUR 368 million
Medacta Group said H1 2026 revenue rose nearly 10% to EUR 368 million. Growth was strong across most regions and segments, but gross margin fell due to FX and mix effects.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Medacta H1 2026 revenue up; EBITDA margin 27.8% constant-currency
Medacta Group says H1 2026 revenue rose nearly 10% to EUR 368 million. Adjusted EBITDA margin was 27.8% at constant currency. Guidance for 10%-14% revenue growth and margin expansion is confirmed.